Benjamin Israelow:
ORCID: https://orcid.org/0000-0002-1308-8246
Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole:
InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: ValidationRole:
VisualizationRole: Writing - original draftRole: Writing - review & editing
Eric Song:
ORCID: https://orcid.org/0000-0001-5448-5865
Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole:
MethodologyRole: ValidationRole: VisualizationRole: Writing - review & editing
Tianyang Mao:
ORCID: https://orcid.org/0000-0001-9251-8592
Role: Formal analysisRole: Investigation
Peiwen Lu:
ORCID: https://orcid.org/0000-0001-6118-872X
Role: InvestigationRole: ResourcesRole: ValidationRole: VisualizationRole: Writing
- review & editing
Amit Meir:
ORCID: https://orcid.org/0000-0001-9635-1021
Role: Data curationRole: Writing - review & editing
Feimei Liu:
ORCID: https://orcid.org/0000-0003-2663-6544
Role: Data curationRole: Formal analysis
Mia Madel Alfajaro:
ORCID: https://orcid.org/0000-0002-6402-2730
Role: Investigation
Jin Wei:
ORCID: https://orcid.org/0000-0002-2832-1610
Role: Resources
Huiping Dong:
ORCID: https://orcid.org/0000-0002-9447-0868
Role: Resources
Robert J. Homer:
ORCID: https://orcid.org/0000-0002-2055-5885
Role: Investigation
Aaron Ring:
ORCID: https://orcid.org/0000-0003-3699-2446
Role: Funding acquisitionRole: Project administrationRole: ResourcesRole: SupervisionRole:
Writing - review & editing
Craig B. Wilen:
ORCID: https://orcid.org/0000-0003-2495-9403
Role: Funding acquisitionRole: ResourcesRole: SupervisionRole: Writing - review &
editing
Akiko Iwasaki:
ORCID: https://orcid.org/0000-0002-7824-9856
Role: ConceptualizationRole: Funding acquisitionRole: InvestigationRole: Project administrationRole:
ResourcesRole: SupervisionRole: VisualizationRole: Writing - review & editing
Journal ID (nlm-ta): J Exp Med
Journal ID (iso-abbrev): J. Exp. Med
Journal ID (publisher-id): jem
Title:
The Journal of Experimental Medicine
Publisher:
Rockefeller University Press
ISSN
(Print):
0022-1007
ISSN
(Electronic):
1540-9538
Publication date Collection: 07
December
2020
Publication date
(Electronic):
04
August
2020
Publication date PMC-release: 04
August
2020
Volume: 217
Issue: 12
Electronic Location Identifier: e20201241
Affiliations
[1
]Department of Immunobiology, Yale University School of Medicine, New Haven, CT
[2
]Department of Internal Medicine, Section of Infectious Diseases, Yale University School
of Medicine, New Haven, CT
[3
]Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven,
CT
[4
]Department of Laboratory Medicine, Yale University School of Medicine, New Haven,
CT
[5
]Department of Pathology, Yale University School of Medicine, New Haven, CT
[6
]Howard Hughes Medical Institute, Chevy Chase, MD
Author notes
Disclosures: A. Ring reported a patent to novel binding partner that interacts with
SARS-CoV2 spike N-terminal domain pending; reports, "Unrelated to the subject of the
work, I have founded, co-founded, and/or hold equity in biotechnology companies including
Simcha Therapeutics, Forty Seven Inc., and ALX Oncology. I have also consulted for
Medicenna Therapeutics, a company that licensed patents I invented in immuno-oncology.
None of these companies are in the SARS-CoV-2 space or work on infectious disease
to my knowledge. Broadly related to the subject of this work, within the past year,
I have purchased and disposed shares in Gilead Sciences and Vir Biotechnology, which
are working on therapeutics in the coronavirus space. I currently hold no shares in
either of those companies." No other disclosures were reported.
[*]
B. Israelow and E. Song contributed equally to this paper.
Author information
Article
Publisher ID:
jem.20201241
DOI: 10.1084/jem.20201241
PMC ID: 7401025
PubMed ID: 32750141
SO-VID: d382321a-cf7f-4b54-a160-8beccbbdedf8
Copyright © © 2020 Israelow et al.
License:
This article is distributed under the terms of an Attribution–Noncommercial–Share
Alike–No Mirror Sites license for the first six months after the publication date
(see
http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share
Alike 4.0 International license, as described at
https://creativecommons.org/licenses/by-nc-sa/4.0/).
Funded by: National Institutes of Health, DOI http://dx.doi.org/10.13039/100000002;
Award ID: 2T32AI007517-16
Award ID: T32GM007205
Award ID: F30CA239444
Award ID: R37AI041699
Award ID: AI054359
Award ID: AI127429
Award ID: T32AI007019
Award ID: K08 AI128043
Funded by: Women’s Health Research at Yale;
Funded by: Mercatus Center;
Funded by: G. Harold and Leila Y. Mathers Foundation, DOI http://dx.doi.org/10.13039/100011671;
Funded by: Ludwig Family Foundation;
Funded by: Howard Hughes Medical Institute, DOI http://dx.doi.org/10.13039/100000011;
